three navel oranges with an increasingly large, prominent navel

Briefly May+Jun 2022

Cabenuva long-acting injectable no longer requires a month of oral lead-in medication
Enid Vázquez

A sense of trust— and a matter of access

By

Let's talk

Doing right by sexual health
By

A clinic on wheels serves people who inject drugs

As health care providers move further into telehealth services, clinics on wheels rolled out in five cities to serve people who inject drugs who are living with or are at risk for HIV.
By

Briefly Jan+Feb 2022

New injectable PrEP given every two months: Apretude
By

PrEPared?

As long-acting treatment and prevention begins to enter communities, we must move toward dismantling systemic racism
By Abraham Johnson, MPH

Briefly Nov+Dec 2021

Long-acting PrEP with cabotegravir could be around the corner
By

Another international HIV conference goes virtual amidst a global pandemic

COVID-19 and PLWH; islatravir for PrEP; lenacapavir for treatment; adherence with vaginal rings and oral PrEP
By

Briefly Sep+Oct 2021

Update on opportunistic infections; third COVID shot for PLWH; syphilis PrEP?
By

Disruptive Innovation Is Key to End HIV-Related Health Disparities for Black Americans

By Stephen S. Tang, Ph.D. and Giffin Daughtridge, M.D.
Subscribe to HIV Prevention